FLUVASTATIN EFFECTS ON BLOOD CELL AGGREGATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA

FLUVASTATIN EFFECTS ON BLOOD CELL AGGREGATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA

Aim. To investigate the effects of fluvastatin on the blood cell aggregation in patients with arterial hypertension (AH) and dyslipidemia (DLP).Material and methods. The main group (MG) included 32 middle-aged patients with Stage 1–2 AH (Risk 3) and Type IIb DLP. The control group (CG) included 26 h...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. N. Medvedev, I. A. Skoryatina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2013-04-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	arterial hypertension dyslipidemia fluvastatin aggregation activity blood cells
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/150
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFECTS OF THERAPY ON THE ABILITY OF ERYTHROCYTES FLUVASTATIN AGGREGATION IN HYPERTENSIVE PATIENTS WITH DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2012-03-01)

Effects of fluvastatin, valsartan, and their combination on endothelial function in patients with arterial hypertension and dyslipidemia
by: T. Sh. Mirilashvili, et al.
Published: (2009-08-01)

Aggregation ability of the main blood cells in arterial hypertension and dyslipidemia patients on rosuvastatin and non-drug treatments
by: I. N. Medvedev, et al.
Published: (2016-10-01)

ANTIPLATELET CONTROL OF VESSELS OVER THE MAIN BLOOD CELLS IN HYPERTENSIVES WITH DYSLIPIDEMIA IN COMPLEX THERAPY
by: I. A. Skorjatina, et al.
Published: (2017-04-01)

TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2
by: O. M. Drapkina, et al.
Published: (2017-07-01)

STATE CONTROL OF THE VASCULAR WALL TO ANTIAGGREGATIVE BY NEUTROPHILS IN PATIENTS ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA PATIENTS TREATED WITH SIMVASTATIN
by: I. N. Medvedev, et al.
Published: (2013-03-01)

USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA
by: O. M. Drapkina, et al.
Published: (2017-09-01)

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFULTRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED FLUVASTATIN EXTENDED RELEASE ADDED TO STANDARD THERAPY. PROTOCOL OF THE OPEN-LABEL OBSERVATIONAL STUDY
by: A. V. Susekov, et al.
Published: (2016-01-01)

Microelements, pro- and anti-oxidant blood activity in arterial hypertension
by: A. R. Antonov, et al.
Published: (2006-10-01)

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFUL TRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED LESCOL XL (FLUVASTATIN) ADDED TO STANDARD THERAPY. RESULTS OF THE LESQOL OPEN-LABEL OBSERVATIONAL STUDY
by: A. V. Susekov, et al.
Published: (2016-01-01)

Prevalence of dyslipidemia and its association with blood pressure control in Iranian hypertensive patients: insights from STEPS 2021
by: Shervin Mossavarali, et al.
Published: (2025-07-01)

EFFICACY AND SAFETY OF BISOPROLOL IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND OBESITY
by: A. G. Avtandilov, et al.
Published: (2016-01-01)

Associations of polyphenolic compounds consumption and the risk of dyslipidemia in the Siberian population
by: T. I. Batluk, et al.
Published: (2020-06-01)

Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER
by: I. A. Zolotovskaya, et al.
Published: (2022-07-01)

Increment of the effectiveness of treating hypertension and dyslipidemia using a triple fixed-dose combination and the vascular age concept
by: O. V. Tsygankova, et al.
Published: (2020-09-01)

Verospiron effects on platelet aggregation in patients with arterial hypertension and abdominal obesity
by: I. N. Medvedev, et al.
Published: (2007-12-01)

Association of Unhealthy Lifestyle Score on the Risk of Hypertension, Dyslipidemia, and Their Comorbidity in Korea: A Cross-Sectional Study
by: Ji-Sook Kong, et al.
Published: (2024-02-01)

Therapy for hypertension and dyslipidemia: potential of Lipertans (on the example of a clinical observation)
by: V. V. Kashtalap
Published: (2022-12-01)

Ramipril effects on cerebral blood flow and microcirculation in patients with essential arterial hypertension
by: L. I. Markova, et al.
Published: (1970-01-01)

Cerebral blood flow and blood rheology in hypertensive patients during rilmenidine treatment
by: L. I. Markova, et al.
Published: (2004-06-01)

DISORDERS OF PLASMA AND PLATELET PATHWAYS OF HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION COMBINED WITH DISLIPOPROTEINEMIA
by: M. Y. Zhuk, et al.
Published: (2003-10-01)

Joint associations of pre-diabetes, pre-hypertension, and pre-dyslipidemia with cardiovascular and metabolic disease progression
by: Cui Ma, et al.
Published: (2025-08-01)

THE CONCERNS OF BLOOD PRESSURE MONITORING IN ARTERIAL HYPERTENSION OUTPATIENTS
by: E. M. Filipchenko, et al.
Published: (2016-04-01)

ALCOHOL AND ARTERIAL HYPERTENSION
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE
by: N. J. Gromnazky, et al.
Published: (2003-12-01)

HYPERVISCOSITY SYNDROME IN ARTERIAL HYPERTENSION AND HEMORHEOLOGICAL EFFECTS OF ANTIHYPERTENSIVE DRUGS
by: A. Yu. Shamanaev, et al.
Published: (2016-04-01)

Circadian blood pressure rhythm and renal function in males with essential arterial hypertension
by: I. G. Fomina, et al.
Published: (2006-08-01)

Dynamics of peripheral blood auto-rosette formation in treated patients with essential arterial hypertension
by: V. S. Volkov, et al.
Published: (1970-01-01)

ARTERIAL HYPERTENSION AND CIRCADIAN BLOOD PRESSURE PROFILE IN CLIMACTERIC WOMEN
by: V. V. Anikin, et al.
Published: (2011-12-01)

Neuro-net model for early arterial hypertension diagnostics using 24-hour blood pressure monitoring data
by: V. G. Vilkov, et al.
Published: (2006-06-01)

PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE
by: V. V. Yakusevich, et al.
Published: (2015-12-01)

Conceptual approaches to cerebral blood flow correction in postmenopausal women with arterial hypertension
by: V. V. Yakusevich, et al.
Published: (2005-04-01)

Blood cells and their effect on the lipid profile in women with essential hypertension
by: B. I. Kuznik, et al.
Published: (2020-04-01)

DYSLIPIDEMIA FEATURES IN CHILDREN
by: T. I. Turkinа, et al.
Published: (2016-01-01)

Optimal treatment strategies in comorbid patients with hypertension and dyslipidemia: the role of fixed-dose combinations
by: A. A. Sokolova, et al.
Published: (2023-12-01)

Lipid profile in children and adolescents with arterial hypertension
by: N. I. Gromnatsky, et al.
Published: (2008-06-01)

Masked inefficacy of arterial hypertension treatment: prevalence and predictors
by: M. I. Smirnova, et al.
Published: (2011-12-01)

Possibilities of telemedicine influence on the level of systolic blood pressure in patients with diabetes mellitus in combination with arterial hypertension
by: F. F. Hajiyeva, et al.
Published: (2023-01-01)

Synergistic effects of NF-κB1 and inflammatory pathway polymorphisms on hypertension and dyslipidemia susceptibility in type 2 diabetes
by: Chao Zuo, et al.
Published: (2025-07-01)

THE RATE AND CHARACTERS OF MASKED ARTERIAL HYPERTENSION AND MASKED INEFFECTIVENESS OF HYPERTENSION TREATMENT IN INDUSTRIAL WORKERS ACCORDING TO THE PREVENTIVE EXAMINATION
by: M. I. Smirnova, et al.
Published: (2015-09-01)